Alcohol Use Disorder (AUD) in New Jersey (NJ) Disparity in Treatment

被引:0
|
作者
Yoade, Bolaji [1 ]
Akinbode, Oluwafemi [2 ]
Olatunji, Olubusola [3 ]
Popoola, Olufemi [4 ]
Busari, Oluwatoyin [5 ]
Odenigbo, Nkolika [6 ]
Kogan, Irina [6 ]
Nkemjika, Stanley [6 ]
机构
[1] Regis Coll, Publ Hlth, Weston, MA 02493 USA
[2] Amer Family Care, Family Med, West Orange, NJ USA
[3] North Kentucky Univ, Coll Hlth Sci & Human Serv, Highland Hts, KY USA
[4] Loyola Univ, Neiswanger Inst Bioeth & Healthcare Leadership, Chicago, IL USA
[5] Univ Hosp Cleveland Med Ctr, Case Western Reserve Univ, Psychiat, Cleveland, OH USA
[6] Interfaith Med Ctr, Psychiat & Behav Sci, Brooklyn, NY USA
关键词
treatment; nj; sociodemographic; disparity; alcohol use disorder; COMPLETION; QUALITY;
D O I
10.7759/cureus.43286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alcohol use disorder (AUD) continues to be a threat to public health due to the associated morbidity, mortality, and social and economic impacts. AUD accounts for greater than 85,000 deaths annually in the United States and greater than 1500 deaths annually in New Jersey (NJ). Despite these associated burdens, the treatment of AUD remains unequal among the population, and it is important to identify the factors influencing the disparity in defined population groups such as NJ to drive the appropriate intervention. Data were retrieved from the 2018 Treatment Episode Data Set-Discharges (TEDS-D) of the United States Substance Abuse and Mental Health Services Administration (SAMHSA). Logistic regression analysis was used to predict the odds of receiving treatment based on socioeconomic factors and the type of treatment received. Compared to Asian or Pacific Islanders in NJ, the American Indian [odds ratio, OR=2.12, 95% confidence interval, CI: 1.95-2.31] has the greatest odds of receiving treatment for AUD, followed by the Black or African American [OR=1.70, 95% CI: 1.65-1.75], the Alaska Native [OR=1.67, 95% CI: 1.42-1.96], and then the White [OR=1.31, 95% CI: 1.12-1.52]. Those who are retired or on disability [OR=0.88, 95% CI: 0.820.94] have lower odds of receiving treatment than those on salary or wages. Those with AUD in NJ have a lower odd of receiving detoxification treatment in a 24-h hospital inpatient setting [OR=0.88, 95% CI 0.820.95] and a higher odd of receiving detoxification treatment in a 24-h service, free-standing residential setting when compared to the treatment received in a rehabilitation/hospital (other than detoxification) setting. This study shows that disparity exists in relation to the type of treatment received and the setting of treatment for AUD in NJ in addition to disparity based on the sociodemographic factors.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] CONCEPTUALIZATION OF ALCOHOL USE DISORDER (AUD): CAN THE HARMFUL DYSFUNCTION OR INABILITY TO BEHAVE ANALYSES OF PSYCHOPATHOLOGY IMPROVE DIAGNOSTIC CRITERIA FOR AUD?
    Scalco, M. D.
    Lorenzo-Luaces, L.
    Sloss, A. D.
    Counce, J. H.
    Evans, M.
    Meisel, S. N.
    Colder, C. R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 144A - 144A
  • [42] Treatment of alcohol use disorder with biperiden: New clinical perspectives
    Galduroz, J. C. F.
    Bezerra, A. G.
    Noto, A. R.
    Formigoni, M. L. O. S.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 240 - 240
  • [43] Immunological Disturbances and Neuroimaging Findings in Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD) Comorbid Patients
    Kakanakova, Andriana
    Popov, Stefan
    Maes, Michael
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (09) : 759 - 769
  • [44] Barriers for treatment and coping with alcohol use disorders (AUD)-A consumer's perspective
    Bischof, Anja
    Schmidt, Hannah
    Brandes, Miriam
    Rumpf, Hans-Jurgen
    Bischof, Gallus
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2022, 17 (SUPPL 1):
  • [45] Blood glutamine synthetase signaling in alcohol use disorder and racial disparity
    Lailun Nahar
    Sarah E. Kaufman
    Patrick G. Davis
    Stephanie L. Saunders
    Elizabeth A. Disbrow
    James C. Patterson
    Hyung W. Nam
    Translational Psychiatry, 12
  • [46] Blood glutamine synthetase signaling in alcohol use disorder and racial disparity
    Nahar, Lailun
    Kaufman, Sarah E.
    Davis, Patrick G.
    Saunders, Stephanie L.
    Disbrow, Elizabeth A.
    Patterson, James C.
    Nam, Hyung W.
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [47] WHAT PREDICTS PERCEIVED SOCIAL SUPPORT IN PATIENTS WITH COMORBID ALCOHOL USE DISORDER (AUD) AND INSOMNIA?
    Thakur, Nina
    He, Sean
    Taylor, Brittany
    Chakravorty, Subhajit
    SLEEP, 2019, 42
  • [48] Optimizing Care and Treatment for Alcohol Use Disorder (AUD) in patients with Alcohol-related Liver Disease (ALD): Year 1 of a national virtual workshop
    Edens, Ellen L.
    Desai, Nitigna
    Moore, Brent A.
    Haque, Lamia
    Perumalswami, Ponni
    Elhara, Nicole
    Mahoney, Bridge
    Falleni, Alyssa
    Spreyer, Kasey
    Morre, David T.
    AMERICAN JOURNAL ON ADDICTIONS, 2024, 33 (02): : 169 - 169
  • [49] Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD)
    Rodriguez, Francisco D.
    Covenas, Rafael
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (23) : 2528 - 2558
  • [50] AUD-DSS: a decision support system for early detection of patients with alcohol use disorder
    Ebrahimi, Ali
    Wiil, Uffe Kock
    Baskaran, Ruben
    Peimankar, Abdolrahman
    Andersen, Kjeld
    Nielsen, Anette Sogaard
    BMC BIOINFORMATICS, 2023, 24 (01)